Every material Form 8-K CRH has filed with the SEC since December 06, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CRH plc said its subsidiary CRH America Finance, Inc. has started cash tender offers for Arcosa, Inc. notes and exchange offers for up to $1.0 billion of new CRH America Finance notes, following CRH's acquisition of Arcosa completed October 23, 2026. Arcosa is also soliciting consents to amend the indentures governing those notes, which would eliminate certain covenants, restrictive provisions, events of default and guarantee provisions. The offers are conditioned on proceeds from a concurrent public offering of senior debt by CRH America Finance, guaranteed by CRH plc, and the filing describes this as a refinancing of acquired debt rather than a change in operating results.
Tender offers cover $400 million of 4.375% notes due 2029 and $600 million of 6.875% notes due 2032
Early tender deadline is November 18, 2026; early settlement expected November 20, 2026; offers expire December 4, 2026
Total tender consideration is $983.75 (2029 notes) and $1,035.00 (2032 notes) per $1,000 principal, including a $50 early tender premium
Exchange offers are capped at up to $1,000,000,000 aggregate principal of new CRH America Finance notes guaranteed by CRH plc
CRH reported third quarter 2026 total revenues of $11.4 billion and net income of $1.2 billion, representing a decrease from the prior year due to impairment losses. The company lowered its full-year 2026 guidance for net income and adjusted EBITDA, citing a challenging residential market and inflationary costs, while announcing a new $6 billion share buyback program running through 2030. Additionally, CRH completed its $8.5 billion acquisition of Arcosa on October 23, 2026.
Total revenues for Q3 2026 were $11.4 billion, up 3% year-over-year, while net income declined to $1.2 billion.
Full-year 2026 guidance was revised to net income of $3.1 billion to $3.3 billion and Adjusted EBITDA of $7.8 billion to $8.0 billion.
CRH completed the $8.5 billion acquisition of Arcosa on October 23, 2026.
A new share buyback program of up to $6 billion was authorized, expiring at the end of 2030.
CRH announced on October 23, 2026 that it has completed its acquisition of Arcosa, Inc., a U.S. aggregates and critical infrastructure provider, for a total enterprise value of approximately $8.5 billion. The company said it will provide updated full-year 2026 guidance reflecting the deal with its third-quarter results on October 29.
Total enterprise value of approximately $8.5 billion, as stated in the press release.
Agreement to acquire Arcosa was first announced on June 22, 2026.
CRH will issue updated full-year 2026 guidance reflecting the acquisition with third-quarter results on October 29.
The filing furnishes the press release as Exhibit 99.1 under Item 7.01 and does not include new financial results.
CRH reported second quarter 2026 results with total revenues of $10.8 billion, up 6% from the prior year, and net income of $1.5 billion, up 13%. The company reaffirmed its full-year 2026 guidance for net income, Adjusted EBITDA and diluted EPS, and said it has not started a new share buyback tranche while the $8.5 billion Arcosa acquisition is pending.
Q2 2026 diluted EPS was $2.21, up from $1.94 in Q2 2025; Adjusted EBITDA was $2.6 billion, up 7%.
Q2 net income included gains on divestitures; income tax expense rose to $661 million from $425 million.
2026 guidance reaffirmed: net income $3.9 billion to $4.1 billion, Adjusted EBITDA $8.1 billion to $8.5 billion, diluted EPS $5.60 to $6.05.
Capital expenditure guidance was lowered to $2.7 billion to $2.9 billion from $2.8 billion to $3.0 billion; no new buyback tranche has started since the Arcosa agreement on June 22, 2026.
CRH agreed on June 21, 2026 to acquire Arcosa, Inc. through a merger in which Arcosa becomes a wholly owned subsidiary, with Arcosa stockholders to receive $150.00 in cash per share. The deal is expected to close in Q1 2027, subject to Arcosa stockholder approval, regulatory approvals and customary conditions, and CRH plans to fund it with available cash and committed debt financing.
Price of $150.00 per share in cash, a 25% premium to Arcosa's 60-day trading VWAP as of June 18, 2026; enterprise value of approximately $8.5 billion
Termination fee of $371,967,952 payable by Parent in certain regulatory-failure circumstances; $260,377,567 payable by Arcosa in certain circumstances
Outside Date of June 21, 2027, extendable by up to six months if only antitrust or regulatory conditions remain unsatisfied
CRH expects $175 million of run-rate cost synergies by year three and pro forma FY 2026E net debt to Adjusted EBITDA of 2.4x
CRH's board increased its size from 12 to 13 members and appointed W. Anthony (Tony) Will as a non-management director, effective July 1, 2026. Will retired in 2026 as president and CEO of CF Industries Holdings, and the filing describes his board pay as following the standard non-management director program.
Board size increases from 12 to 13 members; Will's appointment is effective July 1, 2026
Will served as president, CEO and board member of CF Industries Holdings from 2014 until his retirement in 2026
Will is currently a director of Union Pacific Corporation and formerly a director of Olin Corporation
Filing states Will has no family relationship with directors or executive officers and no related-party transactions requiring disclosure
CRH appointed Aylwyn Bryan as Chief Financial Officer effective May 12, 2026, replacing Nancy Buese, who stepped down by mutual agreement on May 11, 2026. Bryan has spent 14 years at CRH, most recently as CFO of its Americas Division, and the filing states Buese's departure was not due to any disagreement with the company.
Aylwyn Bryan appointed CFO effective May 12, 2026; he is 47 and has served CRH for 14 years
Bryan's employment agreement sets a base salary of $850,000 and a target bonus of 100% of salary, with a maximum of 200%
Bryan receives an additional long-term equity award of $1,563,000 in connection with his appointment
Nancy Buese remains a non-executive employee through August 11, 2026 and is entitled to separation payments subject to a release of claims
CRH reported first quarter 2026 total revenues of $7.4 billion, up 9% from $6.8 billion a year earlier, and adjusted EBITDA of $0.6 billion, up 18%. The net loss widened to $0.2 billion from $0.1 billion, with diluted loss per share of $0.27 versus $0.15, driven by higher depreciation, impairment charges and interest expense; the company reaffirmed its 2026 guidance.
Total revenues were $7.4 billion, up 9% from $6.8 billion in Q1 2025.
Net loss was $0.2 billion versus $0.1 billion a year earlier; diluted loss per share was $0.27 versus $0.15.
Adjusted EBITDA was $0.6 billion, up 18%; 2026 guidance reaffirmed at net income of $3.9 billion to $4.1 billion and adjusted EBITDA of $8.1 billion to $8.5 billion.
Quarterly dividend of $0.39 per share, up 5%; an additional $0.3 billion share buyback tranche to be completed no later than July 28, 2026.
CRH reported fiscal 2025 results with total revenues of $37.4 billion, up 5%, and diluted EPS of $5.51, up 10%. The company also guided to 2026 net income of $3.9 billion to $4.1 billion and diluted EPS of $5.60 to $6.05, and declared a quarterly dividend of $0.39 per share, up 5%.
FY 2025 total revenues $37.4 billion (up 5%); net income $3.8 billion (up 8%); Adjusted EBITDA $7.7 billion (up 11%)
FY 2025 diluted EPS $5.51, up 10%; diluted EPS pre-impairment $5.57, up 3%
2026 guidance: net income $3.9 billion to $4.1 billion; Adjusted EBITDA $8.1 billion to $8.5 billion; diluted EPS $5.60 to $6.05
Quarterly dividend of $0.39 per share, payable April 8, 2026, to holders of record on March 6, 2026
CRH plc disclosed that director Patrick Decker resigned from its Board of Directors effective December 1, 2025, citing unforeseen circumstances. The company said the resignation was not due to any disagreement over its operations, policies or practices, and the Board reduced its size from 13 to 12 members.
Patrick Decker resigned as a Director effective December 1, 2025, citing unforeseen circumstances
The filing states the resignation was not related to any disagreement with the company's operations, policies or practices
Board size reduced from 13 to 12 members following the resignation
CRH reported third-quarter 2025 revenue of $11.1 billion, up 5% from a year earlier, with net income of $1.5 billion (up 9%) and diluted EPS of $2.21 (up 12%). The company reaffirmed its 2025 net income guidance of $3.8 billion to $3.9 billion and raised the midpoint of its adjusted EBITDA guidance to $7.65 billion from $7.6 billion, while also declaring a quarterly dividend of $0.37 per share, up 6%.
Q3 2025 revenue $11.1 billion (up 5%); net income $1.5 billion (up 9%); diluted EPS $2.21 (up 12%)
Adjusted EBITDA $2.7 billion (up 10%); net income margin 13.7%, adjusted EBITDA margin 24.3%
2025 guidance: net income reaffirmed at $3.8 billion to $3.9 billion; adjusted EBITDA midpoint raised to $7.65 billion from $7.6 billion
Quarterly dividend of $0.37 per share, payable Dec. 17, 2025, to holders of record Nov. 21, 2025; net debt rose to $15.0 billion from $10.5 billion at December 31, 2024
CRH's Board increased its size from 12 to 13 members and appointed Patrick Decker as a non-management Director, effective October 1, 2025. Decker is the retired president and CEO of Xylem Inc., and the filing describes his director compensation as following the company's standard non-management director program.
Board size increased from 12 to 13 members; Decker's appointment effective October 1, 2025, decided September 8, 2025
Decker, 60, was president and CEO of Xylem Inc. from March 2014 through December 2023
Decker's RSU award is a pro rata portion of the grant to other non-management directors, covering service until the 2026 Annual General Meeting
Filing states no family relationships or Item 404(a) related-party transactions
CRH reported second-quarter 2025 revenue of $10.2 billion, up 6%, with diluted earnings per share of $1.94, up from $1.88 a year earlier. The company raised its 2025 Adjusted EBITDA and diluted EPS guidance ranges and declared a quarterly dividend of $0.37 per share, up 6%, which matters to shareholders because it reflects higher expected profit and continued cash returns.
Q2 2025 total revenues were $10.2 billion, up 6%; net income was $1.3 billion, up 2%
Diluted EPS was $1.94 versus $1.88 in Q2 2024; Adjusted EBITDA was $2.5 billion, up 9%
2025 Adjusted EBITDA guidance raised to $7.5 billion-$7.7 billion from $7.3 billion-$7.7 billion; diluted EPS guidance raised to $5.49-$5.72 from $5.34-$5.80
Quarterly dividend of $0.37 per share; ex-dividend and record date August 22, 2025; payment date September 24, 2025
CRH's shareholders approved a series of governance changes at the 2025 Annual General Meeting on May 8, 2025, including amendments to the company's Articles effective that day, and re-elected all 12 director nominees. They also approved the CRH plc Equity Incentive Plan, which reserves 15 million ordinary shares and will replace the 2014 Performance Share Plan and other discretionary share plans, with some exceptions.
All 12 director nominees were re-elected; Jim Mintern received 501,900,102 votes for and Richie Boucher received 474,966,274 votes for, with 27,065,642 against.
The Equity Incentive Plan was approved with 483,930,381 votes for and 18,075,734 against.
Shareholders approved amendments to the Articles, including a plurality voting standard for contested director elections and board authority to set its size and director fees.
In an advisory vote, shareholders chose annual 'Say-on-Pay' votes, with 499,105,127 votes for annually.
CRH reported first quarter 2025 results for the period ended March 31, 2025. Total revenues rose 3% to $6.8 billion, but the company posted a net loss of $98 million, compared with net income of $114 million a year earlier, as gains on prior-year divestitures did not recur. Adjusted EBITDA rose 11% to $495 million, and CRH reaffirmed its 2025 guidance, which matters to shareholders because the profit swing and the reaffirmed outlook both bear on expected full-year results.
Total revenues of $6.8 billion, up 3% from $6.5 billion in Q1 2024; net loss of $98 million versus net income of $114 million a year earlier.
Diluted loss per share of ($0.15), compared with diluted earnings per share of $0.16 in Q1 2024.
Adjusted EBITDA of $495 million, up 11%; Adjusted EBITDA margin of 7.3%, up from 6.8%.
2025 guidance reaffirmed: net income of $3.7 billion to $4.1 billion and Adjusted EBITDA of $7.3 billion to $7.7 billion. A $0.37 quarterly dividend was declared and a new $0.3 billion buyback tranche is to be completed no later than August
CRH announced that Nancy Buese, former CFO of Baker Hughes and Newmont, will become its Chief Financial Officer effective May 12, 2025, replacing interim CFO Alan Connolly, who returns to his prior role as Director of Strategic Finance on May 11, 2025. The filing sets out her pay package, including a $1,000,000 base salary and a target equity award of $4,000,000 for 2025, which shareholders may track in future disclosures.
Nancy Buese appointed CFO effective May 12, 2025; Alan Connolly serves as interim CFO until May 11, 2025
Base salary of $1,000,000, target bonus of 110% of base salary, and target 2025 equity award with grant date fair value of $4,000,000
One-time cash bonus of $1,000,000 and one-time RSU grant of $2,000,000 vesting 50% in 2026 and 50% in 2027
Employment agreement dated April 11, 2025; full agreement to be filed with the Form 10-Q for the quarter ended March 31, 2025
CRH reported fourth-quarter and full-year 2024 results on February 26, 2025. Full-year revenue was $35.6 billion, up 2%, while net income rose 15% to $3.5 billion and basic EPS rose 16% to $5.06. The company also guided 2025 net income to $3.7 billion to $4.1 billion and adjusted EBITDA to $7.3 billion to $7.7 billion, and it raised the quarterly dividend to $0.37.
FY 2024 total revenues $35.6 billion, up 2%; net income $3.5 billion, up 15%; adjusted EBITDA $6.9 billion, up 12%
FY 2024 basic EPS $5.06, up 16%; Q4 2024 basic EPS $1.03, up 4%
2025 guidance: net income $3.7 billion to $4.1 billion; adjusted EBITDA $7.3 billion to $7.7 billion; diluted EPS $5.34 to $5.80
Quarterly dividend increased to $0.37 per share; new $0.3 billion share buyback tranche to be completed by May 2, 2025; net debt rose to $10.5 billion
CRH appointed Alan Connolly, its Director of Strategic Finance, as Interim Chief Financial Officer effective January 1, 2025. The appointment coincides with Jim Mintern, the current CFO, becoming Chief Executive Officer on the same date, and the company is searching for a permanent CFO.
Alan Connolly, age 56, a Chartered Accountant with over three decades of finance experience at CRH, becomes Interim CFO effective January 1, 2025.
Jim Mintern, current CFO, will assume the role of Chief Executive Officer effective January 1, 2025, as previously announced on September 24, 2024.
CRH is conducting a search for a permanent CFO with the help of an independent recruitment consultant, considering both internal and external candidates.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CRH filing is on SEC EDGAR ↗. 8-K briefs of other companies →